Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PHILIP LUPO and JEREMY SCHRAW.
PHILIP LUPO
Connection Strength
13.726
JEREMY SCHRAW
  1. Risk of carcinomas among children and adolescents with birth defects. Cancer Epidemiol. 2025 Apr; 95:102748.
    View in: PubMed
    Score: 0.900
  2. Prevalence of congenital anomalies according to maternal race and ethnicity, Texas, 1999-2018. Birth Defects Res. 2024 Jan; 116(1):e2274.
    View in: PubMed
    Score: 0.831
  3. Patterns of co-occurring birth defects in children with anotia and microtia. Am J Med Genet A. 2023 03; 191(3):805-812.
    View in: PubMed
    Score: 0.779
  4. Factors associated with nonsyndromic anotia and microtia, Texas, 1999-2014. Birth Defects Res. 2023 Jan 01; 115(1):67-78.
    View in: PubMed
    Score: 0.774
  5. Associations of demographic and perinatal factors with childhood neuroblastoma in Texas, 1995-2011. Cancer Epidemiol. 2022 06; 78:102165.
    View in: PubMed
    Score: 0.744
  6. Residence in a Hispanic Enclave Is Associated with Inferior Overall Survival among Children with Acute Lymphoblastic Leukemia. Int J Environ Res Public Health. 2021 09 02; 18(17).
    View in: PubMed
    Score: 0.712
  7. A Comprehensive Assessment of Co-occurring Birth Defects among Infants with Non-Syndromic Anophthalmia or Microphthalmia. Ophthalmic Epidemiol. 2021 10; 28(5):428-435.
    View in: PubMed
    Score: 0.678
  8. Risk factors and time trends for isolated craniosynostosis. Birth Defects Res. 2021 01 01; 113(1):43-54.
    View in: PubMed
    Score: 0.671
  9. Comprehensive assessment of the associations between maternal diabetes and structural birth defects in offspring: a phenome-wide association study. Ann Epidemiol. 2021 01; 53:14-20.e8.
    View in: PubMed
    Score: 0.665
  10. Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. Cancer. 2020 08 01; 126(15):3483-3492.
    View in: PubMed
    Score: 0.652
  11. Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia. EBioMedicine. 2019 Oct; 48:49-57.
    View in: PubMed
    Score: 0.625
  12. Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study. Pediatr Blood Cancer. 2026 Aug; 73(8):e70415.
    View in: PubMed
    Score: 0.247
  13. A Population-Based Assessment of Cancer Risk in Children With VACTERL. Am J Med Genet A. 2026 05; 200(5):1004-1011.
    View in: PubMed
    Score: 0.240
  14. Structural birth defects and leukemia risk in children with Down syndrome. Sci Rep. 2025 Dec 11; 16(1):1741.
    View in: PubMed
    Score: 0.239
  15. Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2025 Dec 01; 34(12):2228-2238.
    View in: PubMed
    Score: 0.239
  16. All genetic subtypes of B-cell acute lymphoblastic leukemia exhibit increased incidence rates in children with Down syndrome. Leukemia. 2025 Jun; 39(6):1516-1519.
    View in: PubMed
    Score: 0.228
  17. Environmental health disparities in pediatric cancer: a?report from the Fourth Symposium on Childhood Cancer Health Disparities. Pediatr Hematol Oncol. 2025 Apr; 42(3):186-203.
    View in: PubMed
    Score: 0.228
  18. Newborn screening analytes and structural birth defects among 27,000 newborns. PLoS One. 2024; 19(7):e0304238.
    View in: PubMed
    Score: 0.217
  19. Residential proximity to oil and gas developments and childhood cancer survival. Cancer. 2024 Nov 01; 130(21):3724-3733.
    View in: PubMed
    Score: 0.216
  20. Role of non-chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30822.
    View in: PubMed
    Score: 0.209
  21. Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children. Cancer. 2024 02 01; 130(3):467-475.
    View in: PubMed
    Score: 0.206
  22. Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37?000 controls. Int J Cancer. 2024 01 01; 154(1):41-52.
    View in: PubMed
    Score: 0.203
  23. Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site. Cancer. 2023 10 15; 129(20):3300-3308.
    View in: PubMed
    Score: 0.202
  24. Correction: Urban-rural residence and birth defects prevalence in Texas: a phenome-wide association study. Pediatr Res. 2022 May; 91(6):1625.
    View in: PubMed
    Score: 0.186
  25. Comprehensively evaluating cancer survival in children with birth defects: a population-based assessment. Cancer Causes Control. 2022 Mar; 33(3):483-488.
    View in: PubMed
    Score: 0.182
  26. Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia. Sci Rep. 2021 10 04; 11(1):19613.
    View in: PubMed
    Score: 0.179
  27. Urban-rural residence and birth defects prevalence in Texas: a phenome-wide association study. Pediatr Res. 2022 05; 91(6):1587-1594.
    View in: PubMed
    Score: 0.177
  28. Using primary teeth and archived dried spots for exposomic studies in children: Exploring new paths in the environmental epidemiology of pediatric cancer. Bioessays. 2021 09; 43(9):e2100030.
    View in: PubMed
    Score: 0.175
  29. Leveraging a phenome-wide approach to identify novel exposure-birth defect associations: A proof of concept using maternal smoking and a spectrum of birth defects. Birth Defects Res. 2021 03 15; 113(5):439-445.
    View in: PubMed
    Score: 0.169
  30. A Comprehensive Assessment of the Associations Between Season of Conception and Birth Defects, Texas, 1999-2015. Int J Environ Res Public Health. 2020 09 29; 17(19).
    View in: PubMed
    Score: 0.167
  31. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020 09; 67(9):e28525.
    View in: PubMed
    Score: 0.164
  32. Male Sex and the Risk of Childhood Cancer: The Mediating Effect of Birth Defects. JNCI Cancer Spectr. 2020 Oct; 4(5):pkaa052.
    View in: PubMed
    Score: 0.163
  33. Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. JAMA Oncol. 2019 Aug 01; 5(8):1150-1158.
    View in: PubMed
    Score: 0.154
  34. Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia. PLoS One. 2018; 13(5):e0197408.
    View in: PubMed
    Score: 0.142
  35. Interplay between Genetic Ancestry, Self-reported Race and Ethnicity, and Clinical Factors in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report. Cancer Epidemiol Biomarkers Prev. 2026 May 01; 35(5):710-717.
    View in: PubMed
    Score: 0.061
  36. Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia. Support Care Cancer. 2026 Feb 17; 34(3):209.
    View in: PubMed
    Score: 0.061
  37. An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy. Blood Adv. 2025 Nov 25; 9(22):5802-5810.
    View in: PubMed
    Score: 0.060
  38. Plasma proteome correlations with liver stiffness in pediatric cholestasis implicate epithelial to mesenchymal transition. Hepatol Commun. 2025 Oct 01; 9(10).
    View in: PubMed
    Score: 0.059
  39. Co-occurrence of congenital anomalies and childhood brain tumors in 22 million live births. Neuro Oncol. 2025 Sep 08; 27(7):1910-1922.
    View in: PubMed
    Score: 0.059
  40. Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatr Blood Cancer. 2025 Mar; 72(3):e31477.
    View in: PubMed
    Score: 0.056
  41. An evaluation of genetic predisposition to congenital anomalies and pediatric cancer supports KAT6B as a novel neuroblastoma susceptibility gene. Genet Med Open. 2025; 3:101901.
    View in: PubMed
    Score: 0.055
  42. Congenital Tooth Agenesis and Risk of Early-Onset Cancer. JAMA Netw Open. 2024 03 04; 7(3):e240365.
    View in: PubMed
    Score: 0.053
  43. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019. Pediatr Blood Cancer. 2024 Jan; 71(1):e30732.
    View in: PubMed
    Score: 0.052
  44. Epigenomic signature of major congenital heart defects in newborns with Down syndrome. Hum Genomics. 2023 10 06; 17(1):92.
    View in: PubMed
    Score: 0.051
  45. Identification of USP9X as a leukemia susceptibility gene. Blood Adv. 2023 08 22; 7(16):4563-4575.
    View in: PubMed
    Score: 0.051
  46. Associations between birth defects with neural crest cell origins and pediatric embryonal tumors. Cancer. 2023 11 15; 129(22):3595-3602.
    View in: PubMed
    Score: 0.051
  47. Exome-wide assessment of isolated biliary atresia: A report from the National Birth Defects Prevention Study using child-parent trios and a case-control design to identify novel rare variants. Am J Med Genet A. 2023 06; 191(6):1546-1556.
    View in: PubMed
    Score: 0.050
  48. Characteristics of infections and their risk factors in children with biliary atresia. Clin Res Hepatol Gastroenterol. 2023 04; 47(4):102109.
    View in: PubMed
    Score: 0.049
  49. Innate immune cell dysfunction and systemic inflammation in children with chronic liver diseases undergoing transplantation. Am J Transplant. 2023 01; 23(1):26-36.
    View in: PubMed
    Score: 0.049
  50. Residence in a Latinx enclave and end-induction minimal residual disease positivity among children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2022 Oct; 39(7):650-657.
    View in: PubMed
    Score: 0.046
  51. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 08 01; 44(6):305-312.
    View in: PubMed
    Score: 0.046
  52. Neighborhood Socioeconomic Deprivation and Mortality in Children with Central Nervous System Tumors. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2278-2285.
    View in: PubMed
    Score: 0.045
  53. Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis. Sci Rep. 2021 05 17; 11(1):10410.
    View in: PubMed
    Score: 0.044
  54. Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):584-591.
    View in: PubMed
    Score: 0.043
  55. The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nat Commun. 2021 02 05; 12(1):821.
    View in: PubMed
    Score: 0.043
  56. Cancer Risk by Attained Age among Children with Birth Defects in Arkansas. Cancer Epidemiol. 2020 10; 68:101796.
    View in: PubMed
    Score: 0.041
  57. Tuberous Sclerosis Complex Genotypes and Developmental Phenotype. Pediatr Neurol. 2019 07; 96:58-63.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.